DNA Capital
Venture Capital
Active
São Paulo, Brazil
32
32M
23
3.20
7
0.28
1
- Stages of investment
- Areas of investment
Summary
DNA Capital is the famous VC, which was founded in 2013.
The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Clover Health, Cambridge Epigenetix, Feegow Clinic. Among the most popular fund investment industries, there are Cloud Computing, Biotechnology. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The typical startup value when the investment from DNA Capital is 500 millions - 1 billion dollars. The important activity for fund was in 2018. Considering the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the DNA Capital, startups are often financed by Sequoia Capital, SOSV, First Round Capital. The meaningful sponsors for the fund in investment in the same round are GV, Y Combinator, Varian Medical Systems. In the next rounds fund is usually obtained by Greenoaks Capital, Asset Management Ventures (AMV).
The overall number of key employees were 8.
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 32
- Lead investments
- 7
- Exits
- 1
- Rounds per year
- 3.20
- Follow on index
- 0.28
- Investments by industry
- Health Care (28)
- Medical (12)
- Information Technology (5)
- Wellness (4)
- Pharmaceutical (3) Show 35 more
- Investments by region
-
- Brazil (17)
- United States (11)
- United Kingdom (1)
- China (2)
- Senegal (1)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 63M
- Group Appearance index
- 0.72
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| OMNY | 01 Feb 2018 | Health Care, Hospital, Big Data, Pharmaceutical | Seed | United States, California, San Francisco | |
| Vitable Health | 21 Oct 2020 | Health Care, Health Insurance, Insurance | Seed | 1M | United States, Pennsylvania, Ridley Township |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.